Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Relay Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 14 filings
- 5 insiders, $121.7M in total
- Insiders trading
- 5
- Net value
- −$121.7M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Relay Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bergstrom Donald A | President, R&D | 399,130 | Sep 9, 2026 | 8 |
| Catinazzo Thomas | Chief Financial Officer | 122,851 | Sep 9, 2026 | 12 |
| Patel Sanjiv | President and CEO | 519,500 | Sep 9, 2026 | 6 |
| Rahmer Peter | See remarks | 223,657 | Aug 28, 2026 | 7 |
| SB Investment Advisers (UK) Ltd | 10% Owner | 21,904,963Indirect | Aug 28, 2026 | 1 |
| Softbank Vision Fund (Aiv M2) L.P. | 10% Owner | 21,904,963Indirect | Aug 28, 2026 | 1 |
| SVF Pauling (Cayman) Ltd | 10% Owner | 21,904,963Indirect | Aug 28, 2026 | 1 |
| Hill Linda A | Director | – | Jun 10, 2026 | 1 |
| Ingram Douglas S | Director | – | Jun 10, 2026 | 1 |
| Borisy Alexis | Director | – | Jun 10, 2026 | 1 |
| Coats Lonnel | Director | – | Jun 10, 2026 | 2 |
| Dable Habib J | Director | – | Jun 10, 2026 | 2 |
| Murcko Mark | Director | 996,952 | Jun 10, 2026 | 1 |
| Mazumdar Claire | Director | – | Jun 10, 2026 | 1 |
| Adams Brian | Chief Legal Officer | 371,472 | Jul 30, 2025 | 0 |
| Rubin Jami | Director | 67,242 | Jun 6, 2025 | 0 |
| Kathiresan Sekar | Director | – | Jun 6, 2025 | 0 |
| Shawver Laura | Director | 40,000 | Jun 5, 2024 | 0 |
| Porter Andy | Chief Administrative Officer | 45,164 | Nov 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2025 (view filing) | Oct 28 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −21.7K | $7.29 | −$157.9K | −6.5%313.6K after | |
| Oct 30, 2025 (view filing) | Oct 28-29 | 2 days | Rahmer PeterSee remarks | SSale | −40.5K | $7.40 | −$299.9K | −10.7%337.5K after | 2 lots |
| Nov 4, 2025 (view filing) | Nov 3 | 1 day | Patel SanjivPresident and CEO | SSale | −62.1K | $7.00 | −$434.5K | −8.1%703.2K after | |
| Jan 7, 2026 (view filing) | Jan 6 | 1 day | Patel SanjivPresident and CEO | SSale | −43.2K | $7.82 | −$337.6K | −6.1%661.0K after | |
| Jan 29, 2026 (view filing) | Jan 27-28 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −15.5K | $7.71 | −$119.6K | −5.9%249.3K after | 2 lots |
| Jan 29, 2026 (view filing) | Jan 27-28 | 2 days | Rahmer PeterSee remarks | SSale | −13.0K | $7.71 | −$100.5K | −4.5%276.6K after | 2 lots |
| Jan 29, 2026 (view filing) | Jan 27-28 | 2 days | Bergstrom Donald APresident, R&D | SSale | −21.6K | $7.72 | −$166.7K | −4.9%420.0K after | 2 lots |
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −17.7K | $10.06 | −$178.2K | −7.1%231.6K after | 10b5-1 |
| Apr 9, 2026 (view filing) | Apr 7-9 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −19.5K | $13.19 | −$257.5K | −8.4%213.9K after | 2 lots10b5-1 |
| Apr 30, 2026 (view filing) | Apr 28 | 2 days | Bergstrom Donald APresident, R&D | SSale | −1.49K | $14.79 | −$22.0K | −0.4%418.6K after | |
| Apr 30, 2026 (view filing) | Apr 28 | 2 days | Rahmer PeterSee remarks | SSale | −753 | $14.79 | −$11.1K | −0.3%275.9K after | |
| Apr 30, 2026 (view filing) | Apr 28 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −972 | $14.79 | −$14.4K | −0.5%212.9K after | |
| May 14, 2026 (view filing) | May 14 | Same day | Catinazzo ThomasChief Financial Officer | SSale | −17.7K | $12.86 | −$227.8K | −8.3%195.2K after | 10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Bergstrom Donald APresident, R&D | SSale | −93.5K | $16.94 | −$1.58M | −18.3%418.6K after | 10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −187.2K | $16.97 | −$3.18M | −51.3%177.5K after | 4 lots10b5-1 |
| Jul 2, 2026 (view filing)4:12 PM ET | Jun 30 | 2 days | Rahmer PeterSee remarks | SSale | −50.0K | $19.09 | −$954.5K | −18.1%225.9K after | 10b5-1 |
| Jul 8, 2026 (view filing)5:07 PM ET | Jul 6 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −17.7K | $18.69 | −$331.1K | −10.0%159.7K after | 10b5-1 |
| Jul 8, 2026 (view filing)5:08 PM ET | Jul 7 | 1 day | Patel SanjivPresident and CEO | SSale | −48.2K | $19.58 | −$943.7K | −7.3%615.9K after | 10b5-1 |
| Jul 8, 2026 (view filing)5:11 PM ET | Jul 6 | 2 days | Bergstrom Donald APresident, R&D | SSale | −8.66K | $18.71 | −$162.0K | −2.1%409.9K after | 10b5-1 |
| Jul 30, 2026 (view filing)4:12 PM ET | Jul 28 | 2 days | Bergstrom Donald APresident, R&D | SSale | −2.24K | $18.61 | −$41.6K | −0.5%407.7K after | |
| Jul 30, 2026 (view filing)4:13 PM ET | Jul 28 | 2 days | Rahmer PeterSee remarks | SSale | −748 | $18.61 | −$13.9K | −0.3%228.2K after | |
| Jul 30, 2026 (view filing)4:13 PM ET | Jul 28 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −1.46K | $18.61 | −$27.2K | −0.9%158.3K after | |
| Aug 18, 2026 (view filing)4:16 PM ET | Aug 14 | 4 days | Catinazzo ThomasChief Financial Officer | SSale | −17.7K | $19.74 | −$349.7K | −11.2%140.6K after | 10b5-1 |
| Aug 18, 2026 (view filing)4:17 PM ET | Aug 17 | 1 day | Patel SanjivPresident and CEO | SSale | −48.2K | $20.33 | −$979.9K | −7.8%567.7K after | 10b5-1 |
| Aug 28, 2026 (view filing)9:01 AM ET | Aug 25 | 3 daysLate | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −6.00M | $19.40 | −$116.4M | −21.5%21.9M after | |
| Aug 28, 2026 (view filing)4:43 PM ET | Aug 26 | 2 days | Rahmer PeterSee remarks | SSale | −4.51K | $20.03 | −$90.3K | −2.0%223.7K after | 10b5-1 |
| Sep 9, 2026 (view filing)4:12 PM ET | Sep 8 | 1 day | Patel SanjivPresident and CEO | SSale | −48.2K | $18.94 | −$912.9K | −8.5%519.5K after | 10b5-1 |
| Sep 9, 2026 (view filing)4:15 PM ET | Sep 8 | 1 day | Catinazzo ThomasChief Financial Officer | SSale | −17.7K | $18.94 | −$335.6K | −12.6%122.9K after | 10b5-1 |
| Sep 9, 2026 (view filing)4:17 PM ET | Sep 8 | 1 day | Bergstrom Donald APresident, R&D | SSale | −8.53K | $18.97 | −$161.8K | −2.1%399.1K after | 10b5-1 |